Merck (MRK) Inventory Average (2009 - 2026)
Merck's (MRK) quarterly Inventory Average came in at $6.3 billion in Q2 2026, down 0.87% year-over-year from $6.4 billion in Q2 2025, and down 3.43% quarter-over-quarter from $6.6 billion in Q1 2026.
Analysis
Merck (MRK) Inventory Average (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Inventory Average for 18 consecutive years, with $6.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory Average fell 0.87% year-over-year to $6.3 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 0.87% decrease from a year earlier, with the FY2025 full-year figure at $6.4 billion, up 2.41% from the prior year.
- Inventory Average was $6.3 billion for Q2 2026 at Merck, down from $6.6 billion in the prior quarter.
- Over five years, Inventory Average peaked at $6.6 billion in Q1 2026 and troughed at $5.6 billion in Q3 2022.
- A 5-year average of $6.2 billion and a median of $6.2 billion in 2023 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average declined 4.97% in 2022 and grew 10.06% in 2024, its largest moves.
- Over 5 years, Inventory Average stood at $5.8 billion in 2022, then gained by 8.36% to $6.2 billion in 2023, then declined by 1.09% to $6.2 billion in 2024, then increased by 6.06% to $6.6 billion in 2025, then slipped by 3.18% to $6.3 billion in 2026.
- The last three Inventory Average figures came in at $6.3 billion (Q2 2026), $6.6 billion (Q1 2026), and $6.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.86 Bn | 621.10 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 446.73 Bn | 440.17 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 357.89 Bn | 350.75 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 267.68 Bn | 259.99 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 156.81 Bn | 145.11 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.21 Bn | 44.83 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.14 Bn | 43.14 Bn | - | - |
| 8 | Incyte | 24.64 Bn | 20.11 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Neurocrine Biosciences | 15.88 Bn | 15.49 Bn | 935.80 Mn | 84.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.34 Bn |
| Mar 31, 2026 | 6.57 Bn |
| Dec 31, 2025 | 6.55 Bn |
| Sep 30, 2025 | 6.52 Bn |
| Jun 30, 2025 | 6.40 Bn |
| Mar 31, 2025 | 6.15 Bn |
| Dec 31, 2024 | 6.18 Bn |
| Sep 30, 2024 | 6.36 Bn |
| Jun 30, 2024 | 6.49 Bn |
| Mar 31, 2024 | 6.43 Bn |
| Dec 31, 2023 | 6.24 Bn |
| Sep 30, 2023 | 6.03 Bn |
| Jun 30, 2023 | 5.90 Bn |
| Mar 31, 2023 | 5.89 Bn |
| Dec 31, 2022 | 5.76 Bn |
| Sep 30, 2022 | 5.57 Bn |
| Jun 30, 2022 | 5.65 Bn |
| Mar 31, 2022 | 5.86 Bn |
| Dec 31, 2021 | 5.78 Bn |
| Sep 30, 2021 | 5.55 Bn |